Summary
Edwards Lifesciences Corporation (EW) has announced the upcoming retirement of Donald E. Bobo, Jr., Corporate Vice President of Strategy and Corporate Development. Mr. Bobo intends to retire by mid-year 2027, with a transition of his duties expected to occur during 2027. The company has initiated a search process to identify his successor. Following his retirement, Mr. Bobo is expected to continue contributing to the company as a consultant until the end of 2027, ensuring a smooth handover and continued strategic support.
Key Highlights
- 1Donald E. Bobo, Jr., Corporate Vice President, Strategy and Corporate Development, will retire by mid-year 2027.
- 2A search for Mr. Bobo's successor has commenced.
- 3The transition of duties is anticipated to take place during 2027.
- 4Mr. Bobo will serve as a consultant to the company through the end of 2027 post-retirement.
- 5This announcement pertains to a key executive role focused on strategy and corporate development.
Frequently Asked Questions
Mr. Bobo is expected to retire from his executive role by mid-year 2027.
While a successor is being sought, Mr. Bobo will continue as a consultant through the end of 2027, which should help ensure continuity and support the transition of responsibilities.
This role is crucial for identifying and executing strategic initiatives, mergers, acquisitions, and other corporate development activities that drive the company's growth and competitive positioning.
No, the company has stated that a selection process will begin promptly to identify a successor.